These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8099078)

  • 1. Two patients with Cushing's disease in a kindred with multiple endocrine neoplasia type I.
    Gaitan D; Loosen PT; Orth DN
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1580-2. PubMed ID: 8099078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association of familial hyperparathyroidism and Cushing's disease].
    Gancel A; Courtois H; Dubois D; Meyer M; Dero J
    Rev Med Interne; 1984 Sep; 5(3):201-4. PubMed ID: 6150531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple endocrine adenomatosis presenting as Cushing's syndrome and concurrent hyperparathyroidism with massive gastric hemorrhage. (Case report with ACTH, parathyroid hormone, and gastrin assays).
    Lohrenz FN; Mallin SR; Ellison EH; Lawton BR
    Wis Med J; 1968 Apr; 67(4):209-15. PubMed ID: 4388572
    [No Abstract]   [Full Text] [Related]  

  • 4. Cushing's syndrome in patients with the Zollinger-Ellison syndrome.
    Maton PN; Gardner JD; Jensen RT
    N Engl J Med; 1986 Jul; 315(1):1-5. PubMed ID: 2872593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of Cushing's syndrome. The diagnostic value of the dexamethasone suppression test, the metopirone test and the CRF test].
    Johannesen O; Jørgensen H; Frey H; Norman N
    Tidsskr Nor Laegeforen; 1989 Sep; 109(26):2678-82. PubMed ID: 2554527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC; Raff H; Findling JW
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cushing's disease in two sisters.
    Gardner DF; Barlascini CO; Downs RW; Sahni KS
    Am J Med Sci; 1989 Jun; 297(6):387-9. PubMed ID: 2544092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cushing's syndrome masked by primary hyperparathyroidism.
    Tajima A; Kawabe K
    J Urol; 1977 Oct; 118(4):669-70. PubMed ID: 21307
    [No Abstract]   [Full Text] [Related]  

  • 9. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple endocrine neoplasia type I with Cushing's disease, primary hyperparathyroidism, and insulin-glucagonoma.
    Miyagawa K; Ishibashi M; Kasuga M; Kanazawa Y; Yamaji T; Takaku F
    Cancer; 1988 Mar; 61(6):1232-6. PubMed ID: 2893661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of primary hyperparathyroidism, primary hyperaldosteronism and Cushing's disease.
    Herd GW
    Acta Endocrinol (Copenh); 1984 Nov; 107(3):371-4. PubMed ID: 6150593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease: multiple endocrine neoplasia, type 2.
    Steiner AL; Goodman AD; Powers SR
    Medicine (Baltimore); 1968 Sep; 47(5):371-409. PubMed ID: 4386574
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Cushing's syndrome: diurnal rhythm and responses to various stimuli.
    Orth DN; Peterson ME; Drucker WD
    Endocrinology; 1988 Apr; 122(4):1250-62. PubMed ID: 3126032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease.
    Dickstein G; DeBold CR; Gaitan D; DeCherney GS; Jackson RV; Sheldon WR; Nicholson WE; Orth DN
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2934-41. PubMed ID: 8768855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The diagnosis of Cushing's syndrome. Results of diagnostic assessment of 20 patients with Cushing's syndrome of variable etiology (1979-1989)].
    Caduff F; Staub JJ; Nordmann A; Radü EW; Landolt H
    Schweiz Med Wochenschr; 1991 Jan; 121(1-2):10-20. PubMed ID: 1990418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cushing's disease in childhood as the first manifestation of multiple endocrine neoplasia syndrome type 1.
    Rix M; Hertel NT; Nielsen FC; Jacobsen BB; Hoejberg AS; Brixen K; Hangaard J; Kroustrup JP
    Eur J Endocrinol; 2004 Dec; 151(6):709-15. PubMed ID: 15588237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenomenology and family history of affective disorder in Cushing's disease.
    Hudson JI; Hudson MS; Griffing GT; Melby JC; Pope HG
    Am J Psychiatry; 1987 Jul; 144(7):951-3. PubMed ID: 3605410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic tests in the diagnosis and differential diagnosis of Cushing's syndrome.
    Morris DG; Grossman AB
    J Endocrinol Invest; 2003; 26(7 Suppl):64-73. PubMed ID: 14604068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial adrenocorticotropin-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia.
    Findlay JC; Sheeler LR; Engeland WC; Aron DC
    J Clin Endocrinol Metab; 1993 Jan; 76(1):189-91. PubMed ID: 8380604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in response to dexamethasone of a patient with Cushing's syndrome.
    Rorstad O; Urtasun R; Watanabe M
    Can Med Assoc J; 1976 Nov; 115(9):878-9. PubMed ID: 991035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.